BCHE and dementia: Galantamine HBr is a reversible, competitive cholinesterase inhibitor and a positive allosteric modulator of nicotinic receptors [2] approved in the USA for the treatment of mild-to-moderately severe dementia of Alzheimer type, and for Alzheimer’s disease (AD) with cerebrovascular disease in certain other countries.